Immunization financing in developing countries and the international vaccine market
Subtitle: trends and issues.
Publisher: Asian Development Bank
Published: 2001
Place of publication: Manila, Philippines
Language: eng
Number of pages: 53
Subjects: Immunization -- Developing countries -- Finance.; Vaccines -- Economic aspects -- Developing countries.
Notes: Includes bibliographical references (p. [49]-53).
Table of contents: title: Machine generated contents note: Trends in Grant Financing for Vaccines and Immunization Programs; title: Declining Donor Funding; title: Shifting Donor Focus; title: Global Alliance for Vaccines and Immunization; title: International Vaccine Procurement and Financing Mechanisms; title: The PAHO Revolving Fund; title: Description; title: Benefits; title: Accomplishments; title: Assessment; title: The Vaccine Independence Initiative; title: Description; title: Participation; title: Capitalization; title: Assessment; title: Impact of Vaccine Procurement Mechanisms; title: Program performance; title: Government financing and sustainability of immunization programs; title: Lessons learned; title: The International Vaccine Market: Major Issues; title: Main Characteristics; title: Dominance by a few manufacturers; title: Limited worldwide buyers; title: High degree of segmentation and tiered pricing; title: Scale sensitivity of vaccine development and production; title: Factors Affecting Prices; title: Development and production costs; title: Demand; title: Predictability of demand; title: Production capacity; title: Competition; title: Local producers; title: Intellectual property rights; title: Effects of These Factors on Vaccine Price Trends; title: DPT; title: OPV; title: Recent Developments Formalizing and Expanding Tiered Pricing; title: The Mercer study; title: The "banding"strategy; title: GAVI; title: Different Approaches to Pricing; title: Planned tiered pricing; title: Bulk purchasing/Uniform pricing; title: The Price History of Hepatitis B Vaccine: A Case Study; title: Introduction; title: Plasma-derived vaccine; title: Recombinant DNA vaccine; title: Plasma-Derived Vaccine; title: More accessible technology and increased number of manufacturers; title: Creation of the Hepatitis B Task Force; title: The model Hepatitis B program and international tender; title: Increased competition, production capacity, and interest in; title: recombinant DNA vaccine; title: Recombinant DNA Vaccine; title: Limited number of licensees for the Biogen patent; title: Competition with the plasma-derived vaccine; title: Increased competition; title: Increased demand; title: Summary; title: Lessons learned.